Showing results (551-560 of 746) with videos related to
Sort By:
Pageof 75
Alimentary Pharmacology & Therapeutics|November 2, 2007
New algorithm for the treatment of gastro-oesophageal reflux diseaseG N Tytgat, K McColl, J Tack, et al.Diabetic Medicine : a Journal of the British Diabetic Association|March 5, 2002
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patientsE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.British Journal of Clinical Pharmacology|October 9, 2015
The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinomaAnna Maria J Thijs, Cees J Tack, Winette T A van der Graaf, et al.The Netherlands Journal of Medicine|August 12, 2005
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivityL J H van Tits, E Arioglu-Oral, C G J Sweep, et al.Alimentary Pharmacology & Therapeutics|June 9, 2007
Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux diseaseJ M Conchillo, M P Schwartz, M Selimah, et al.Clinical Science (London, England : 1979)|March 1, 2002
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetesE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.Antimicrobial Agents and Chemotherapy|July 1, 1997
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study GroupJ M Gwaltney, S Savolainen, P Rivas, et al.Alimentary Pharmacology & Therapeutics|February 16, 2011
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux diseaseF Zerbib, S Bruley des Varannes, S Roman, et al.Neurogastroenterology and Motility|May 22, 2016
The effect of arabinoxylooligosaccharides on gastric sensory-motor function and nutrient tolerance in manE Scarpellini, E Deloose, R Vos, et al.The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrineBastiaan E De Galan, Cees J Tack, Jacques J Willemsen, et al.Pageof 75